Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Park Avenue Compounding
WARNING LETTER
•Park Avenue Compounding•August 14, 2014

Park Avenue Compounding – FDA Warning Letter, Aug 14, 2014

Record Details

The FDA issued a Warning Letter to SSM Health Care St. Louis dba SSM St. Clare Health Center, an outsourcing facility, following an inspection from August 4-14, 2014. The inspection revealed serious deficiencies in sterile drug product production, putting patients at risk.

Violations include insanitary conditions, such as an operator using an IV bag dropped on the floor, and failure to demonstrate adequate protection of the ISO 5 area. The facility also failed to meet 503B conditions, leading to adulterated and misbranded drug products. Specific CGMP violations cited include inadequate personnel clothing, lack of validated aseptic processes, insufficient environmental monitoring, incomplete batch records, and failure to investigate out-of-specification results.

Additionally, compounded drug product labels lacked required information like dosage form, compounding date, storage instructions, and complete adverse event reporting details (MedWatch phone number). The facility also failed to submit required 6-month compounding reports to the FDA.

The FDA found the facility's August 22, 2014, response to the Form FDA 483 deficient, noting incomplete label corrections, inadequate smoke study documentation, and a policy allowing use of dropped medications. The beyond-use dates for some products lacked supporting data, and media fill procedures were not representative of actual manufacturing.

The FDA recommends a comprehensive assessment of operations, potentially with a third-party consultant, to ensure CGMP compliance. Failure to correct violations

Company
Park Avenue Compounding
Inspection date
August 14, 2014
Product type
Drugs
Office
Kansas City District Office
People
  • Cheryl A. Bigham (Division Director)
  • Danial S. Hutchison (Investigator)
View Company Profile

ID · edb33a9b-862c-4aaf-b7f6-12edd372e8a8

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 353b21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 360eee-121 U.S.C. 351(a)(2)(A)21 CFR 21021 CFR 21121 CFR 211.28(a)21 CFR 211.113(b)

Full citation text and observation details available on the Dashboard.

Other documents for Park Avenue Compounding
  • 483 - 2025-09-11September 11, 2025
  • 483 - 2024-02-08February 8, 2024
  • 483 - 2021-09-28September 28, 2021
  • 483 - 2019-08-28August 28, 2019
  • 483 - 2017-11-16November 16, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Park Avenue Compounding
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.